Which of the following best describes the action of dobutamine?

Dobutamine primarily acts as a β1 adrenergic agonist, which increases cardiac contractility and heart rate, making it especially useful in the treatment of heart failure and certain types of shock. It can also have mild β2 agonist activity, although its primary therapeutic effects are attributed to β1 receptor stimulation. This action leads to an increase in stroke volume and cardiac output, which is beneficial in managing acute heart conditions.

While it does have some α agonist activity, this is generally minimal compared to its β1 effects. The primary mechanism of action relevant to clinical use is its positive inotropic effect through β1 stimulation. Therefore, characterizing dobutamine’s action solely as an α agonist or antagonizing both β1 and β2 receptors does not accurately reflect its pharmacological profile. Instead, recognizing the dominant β1 agonist activity is key to understanding how dobutamine functions in clinical settings.